Core Viewpoint - Kefu Medical plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and brand recognition [1] Group 1: Company Strategy - The company aims to accelerate its global strategic layout and improve its overseas business development capabilities [1] - The funds raised from the H-share issuance will be used for product R&D innovation, global sales network expansion, business development, brand marketing, and supplementing working capital [1] Group 2: Issuance Details - The issuance will consist of a public offering in Hong Kong and an international placement for qualified institutional investors [1] - The number of H-shares to be issued will not exceed 15% of the company's total share capital prior to the issuance, with an option for an overallotment of up to 15% based on market conditions [1] - Specific details regarding the issuance and listing are yet to be finalized [1]
可孚医疗拟申请港交所主板上市